Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03059940 · ClinicalTrials.gov registry record · Early Phase 1
Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
A Early Phase 1 study of Smoking Cessation, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Early Phase 1
- Development phase
- 630
- Enrollment target
- 1
- Study location
NCT03059940: Active Early Phase 1 study of Smoking Cessation, sponsored by M.D. Anderson Cancer Center.
NCT03059940 is a Early Phase 1 study of Smoking Cessation that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 630 participants, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (34% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03059940, a Early Phase 1 study of Smoking Cessation, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 630 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research study is to offer lung cancer screenings to smokers who want to change their smoking behaviors. All eligible participants will receive smoking cessation counseling and may be offered at least one form of smoking cessation drug. Different forms of counseling (the delivery of counseling and access to counseling) will be compared. This is an investigational study. Participants on this study will not be prescribed smoking drugs directly by the study staff. However, participants in this study may or may not receive smoking cessation drugs, depending on what the provider thinks is in the participants best interest. All smoking cessation drugs being used are FDA approved and commercially available. It is investigational to compare the different forms of counseling participants receive. Up to 1260 participants will be enrolled in this study. All will take part at MD Anderson.
Primary Outcome
Statistical power will focus on primary objective. Primary analyses use intention-to-treat (ITT) principles, with missing observations imputed as smoking.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- BEHAVIORAL Quitline
- PROCEDURE Low Dose Computed Tomography Scan
- OTHER Shared Decision Making + Video
- BEHAVIORAL Cessation Counseling
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 630 participants |
| Start Date | 2017-06-16 |
| Est. Completion | 2026-06-01 |
| Phase | Early Phase 1 |
What the registry record for NCT03059940 still lists
NCT03059940 is an interventional study that assigns participants to a tested intervention. The registered 630 participants enrollment target is mid-sized for trials with a published cap, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (34% higher).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 5 interventions - of which Questionnaires is the first listed.
NCT03059940 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03059940 about?
NCT03059940 is a clinical study titled "Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer". The goal of this clinical research study is to offer lung cancer screenings to smokers who want to change their smoking behaviors. All eligible participants will receive smoking cessation counseling and may be offered at least one form of smoking cessation drug. Different forms of counseling (the de...
What is the current status of trial NCT03059940?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 630 participants. The study started on 2017-06-16. Estimated completion is 2026-06-01.
What conditions does trial NCT03059940 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT03059940?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Quitline (BEHAVIORAL), Low Dose Computed Tomography Scan (PROCEDURE), Shared Decision Making + Video (OTHER), Cessation Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT03059940?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03059940 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03059940's enrollment target sits among peer trials
630 45th of 188 higher than 144 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation Treatment for Head & Neck Cancer Patients
ACTIVE NOT RECRUITING · Early Phase 1
-
End Nicotine Dependence Clinic
COMPLETED · Early Phase 1
-
Hollings Cancer Center Varenicline Sampling Study
COMPLETED · Early Phase 1
-
Applying mHealth to Tobacco-related Health Disparities
COMPLETED · Early Phase 1
-
Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
COMPLETED · Early Phase 1
-
Smoking by IV Pulsed Nicotine
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI